← Eichor
Condition: Follicular Thyroid Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Follicular Thyroid Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Studies on Tumors of the Thyroid
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001160XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Phase 2 · 2 location(s) · Jochen Lorch · NCT06959641Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Phase 2 · 6 location(s) · Massachusetts General Hospital · NCT05668962Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyr
NA · 1 location(s) · Mayo Clinic · NCT07545837Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment
Phase N/A · 1 location(s) · Shanghai 6th People's Hospital · NCT06730321Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06440850Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT05575440Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Di
Phase N/A · 1 location(s) · IRCCS SYNLAB SDN · NCT06878534
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.